Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

1.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005049. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD005049.

PMID:
17943835
[PubMed - indexed for MEDLINE]
2.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J.

Cochrane Database Syst Rev. 2012 May 16;5:CD005049. doi: 10.1002/14651858.CD005049.pub3. Review.

PMID:
22592700
[PubMed - indexed for MEDLINE]
3.

Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.

Lafuente-Lafuente C, Mouly S, Longás-Tejero MA, Mahé I, Bergmann JF.

Arch Intern Med. 2006 Apr 10;166(7):719-28. Review.

PMID:
16606807
[PubMed - indexed for MEDLINE]
4.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
[PubMed - indexed for MEDLINE]
5.

Atrial fibrillation: rate control often better than rhythm control.

[No authors listed]

Prescrire Int. 2004 Apr;13(70):64-9.

PMID:
15148984
[PubMed - indexed for MEDLINE]
6.

Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.

Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM.

Card Electrophysiol Rev. 2003 Sep;7(3):201-7. Review.

PMID:
14739713
[PubMed - indexed for MEDLINE]
7.

Dronedarone for the treatment of atrial fibrillation and atrial flutter.

Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.

Health Technol Assess. 2010 Oct;14(Suppl. 2):55-62. doi: 10.3310/hta14suppl2/08. Review.

PMID:
21047492
[PubMed - indexed for MEDLINE]
Free Article
8.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

PMID:
18547499
[PubMed - indexed for MEDLINE]
Free Article
9.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
[PubMed - indexed for MEDLINE]
10.

Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.

Deneer VH, Borgh MB, Kingma JH, Lie-A-Huen L, Brouwers JR.

Pharm World Sci. 2004 Apr;26(2):66-78. Review.

PMID:
15085940
[PubMed - indexed for MEDLINE]
11.

[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].

Koenig A, Theolade R, Chauvin M, Brechenmacher C.

Presse Med. 1993 Nov 20;22(36):1827-32. Review. French.

PMID:
8309912
[PubMed - indexed for MEDLINE]
12.

Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.

Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A.

Heart. 2002 May;87(5):443-8.

PMID:
11997417
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.

Singh BN, Mody FV, Lopez B, Sarma JS.

Am J Cardiol. 1999 Nov 4;84(9A):161R-173R. Review.

PMID:
10568677
[PubMed - indexed for MEDLINE]
14.

Rate versus rhythm control in atrial fibrillation.

Wijffels MC, Crijns HJ.

Cardiol Clin. 2004 Feb;22(1):63-9. Review.

PMID:
14994848
[PubMed - indexed for MEDLINE]
15.

Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.

Hilleman DE, Spinler SA.

Pharmacotherapy. 2002 Jan;22(1):66-74.

PMID:
11794432
[PubMed - indexed for MEDLINE]
16.

Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.

Arsenault KA, Yusuf AM, Crystal E, Healey JS, Morillo CA, Nair GM, Whitlock RP.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD003611. doi: 10.1002/14651858.CD003611.pub3. Review.

PMID:
23440790
[PubMed - indexed for MEDLINE]
17.

Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.

Wijffels MC, Dorland R, Allessie MA.

J Cardiovasc Electrophysiol. 1999 Feb;10(2):178-93.

PMID:
10090222
[PubMed - indexed for MEDLINE]
18.

Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.

Miller MR, McNamara RL, Segal JB, Kim N, Robinson KA, Goodman SN, Powe NR, Bass EB.

J Fam Pract. 2000 Nov;49(11):1033-46.

PMID:
11093570
[PubMed - indexed for MEDLINE]
19.

Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm.

Marcus GM, Sung RJ.

Cardiology. 2001;95(1):1-8. Review.

PMID:
11385184
[PubMed - indexed for MEDLINE]
20.

Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.

Crijns HJ.

Drugs. 2005;65(12):1651-67. Review.

PMID:
16060699
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk